JP2020519627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519627A5 JP2020519627A5 JP2019562255A JP2019562255A JP2020519627A5 JP 2020519627 A5 JP2020519627 A5 JP 2020519627A5 JP 2019562255 A JP2019562255 A JP 2019562255A JP 2019562255 A JP2019562255 A JP 2019562255A JP 2020519627 A5 JP2020519627 A5 JP 2020519627A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- use according
- composition
- item
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506135P | 2017-05-15 | 2017-05-15 | |
| US62/506,135 | 2017-05-15 | ||
| PCT/US2018/032699 WO2018213266A1 (en) | 2017-05-15 | 2018-05-15 | Methods of use of soluble cd24 for neuroprotection and remyelination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519627A JP2020519627A (ja) | 2020-07-02 |
| JP2020519627A5 true JP2020519627A5 (https=) | 2021-05-06 |
Family
ID=64274583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562255A Pending JP2020519627A (ja) | 2017-05-15 | 2018-05-15 | 神経保護および再ミエリン化のための可溶性ｃｄ２４の使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20200181235A1 (https=) |
| EP (1) | EP3624838B1 (https=) |
| JP (1) | JP2020519627A (https=) |
| KR (1) | KR20200034957A (https=) |
| CN (1) | CN110650749A (https=) |
| CA (1) | CA3063894A1 (https=) |
| TW (1) | TW201900671A (https=) |
| WO (1) | WO2018213266A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130231464A1 (en) | 2010-04-28 | 2013-09-05 | Oncolmmune, Inc. | Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| WO2020084034A1 (en) | 2018-10-26 | 2020-04-30 | F. Hoffmann-La Roche Ag | Multispecific antibody screening method using recombinase mediated cassette exchange |
| WO2021160170A1 (en) * | 2020-02-10 | 2021-08-19 | Oncoimmune, Inc. | Methods of use of soluble cd24 for treating sars-cov-2 infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067110B1 (en) * | 1999-07-21 | 2006-06-27 | Emd Lexigen Research Center Corp. | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| US20030106084A1 (en) * | 2000-03-29 | 2003-06-05 | Yang Liu | Methods of blocking tissue destruction by autoreactive T cells |
| AU2001259792B2 (en) * | 2000-03-29 | 2005-12-22 | The Ohio State University Research Foundation | Methods of blocking tissue destruction by autoreactive T cells |
| US20130231464A1 (en) * | 2010-04-28 | 2013-09-05 | Oncolmmune, Inc. | Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| US8808697B2 (en) * | 2010-04-28 | 2014-08-19 | Oncoimmune, Inc. | Methods of use of soluble CD24 for therapy of rheumatoid arthritis |
| US10689447B2 (en) * | 2011-02-04 | 2020-06-23 | Genentech, Inc. | Fc variants and methods for their production |
| CA2887682A1 (en) * | 2012-10-09 | 2014-04-17 | Biogen Idec Ma Inc. | Combination therapies and uses for treatment of demyelinating disorders |
-
2018
- 2018-05-15 EP EP18801838.6A patent/EP3624838B1/en active Active
- 2018-05-15 CA CA3063894A patent/CA3063894A1/en not_active Abandoned
- 2018-05-15 JP JP2019562255A patent/JP2020519627A/ja active Pending
- 2018-05-15 CN CN201880030068.0A patent/CN110650749A/zh active Pending
- 2018-05-15 TW TW107116447A patent/TW201900671A/zh unknown
- 2018-05-15 KR KR1020197036774A patent/KR20200034957A/ko not_active Ceased
- 2018-05-15 US US16/613,339 patent/US20200181235A1/en not_active Abandoned
- 2018-05-15 WO PCT/US2018/032699 patent/WO2018213266A1/en not_active Ceased
-
2021
- 2021-09-30 US US17/490,505 patent/US20220098278A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12454570B2 (en) | Compositions and methods for growth factor modulation | |
| TWI734722B (zh) | 使用胃抑肽受體（gipr）結合蛋白與glp-1促效劑之組合來治療或改善代謝病症之方法 | |
| JP7780158B2 (ja) | ＲＧＭａ結合タンパク質及びその使用 | |
| RU2580012C2 (ru) | Препарат антитела | |
| US20170002060A1 (en) | Polynucleotides for the in vivo production of antibodies | |
| US20220259308A1 (en) | Fcrn antibodies and methods of use thereof | |
| CA2947967A1 (en) | Compositions and methods for growth factor modulation | |
| JP2013527168A5 (https=) | ||
| RU2010122053A (ru) | Иммуносупрессорные полипептиды и нуклеиновые кислоты | |
| JP2020519627A5 (https=) | ||
| CN112399975B (zh) | 与Tie2结合的抗体及其用途 | |
| AU2024266887A1 (en) | Epitope of regulatory T cell surface antigen and antibody specifically binding thereto | |
| JP2020535811A5 (https=) | ||
| JP2019506408A5 (https=) | ||
| HK40048816A (en) | Compositions and methods for growth factor modulation | |
| EA050428B1 (ru) | АНТИТЕЛА ПРОТИВ FcRn И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |